SCHEMBL734639

SCHEMBL734639

CCOC(=O)CC1(O)C(=O)Nc2cc(Cl)c(Cl)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
CBX7 O95931 2/20 0.43
CDYL Q9Y232 2/20 0.43
CDYL2 Q8N8U2 1/20 0.43
CDY1; CDY1B Q9Y6F8 1/20 0.43
GHSR Q92847 4/20 0.39
ADCY8 P40145 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
BRD4 O60885 2/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733450 0.78 ALDH1A1 (0.58) IDO1CBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL699106 0.78 IDO1 (0.48) IDO1CBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL27780994 0.78 USP2 (0.55) IDO1CBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL5678507 0.76 BRD4 (0.45) GHSRADCY8SMN1; SMN2BRD4POLB
SCHEMBL5675743 0.75 ALDH1A1 (0.47) GHSRADCY8BRD4ALDH1A1
SCHEMBL27780980 0.75 ALDH1A1 (0.47) IDO1MAPTLMNAALDH1A1
SCHEMBL15337230 0.73 MMP2 (0.62) IDO1CBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL15264189 0.71 IDO1 (0.63) IDO1CBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL14547272 0.71 GHSR (0.37) GHSRADCY8SMN1; SMN2MAPTPOLB
5-Fluoroisatin SCHEMBL734148 0.70 MAOB (0.41) IDO1CBX7CDYLCDYL2CDY1; CDY1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 IDO1 2394/4885CBX7 1604/4885CDYL 716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.